Koshinski Asset Management Inc. increased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,474 shares of the financial services provider’s stock after purchasing an additional 115 shares during the period. Koshinski Asset Management Inc.’s holdings in CME Group were worth $807,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Meyer Handelman Co. purchased a new position in CME Group during the fourth quarter worth about $6,144,000. Worldquant Millennium Advisors LLC boosted its stake in CME Group by 58.4% during the third quarter. Worldquant Millennium Advisors LLC now owns 613,828 shares of the financial services provider’s stock worth $135,441,000 after buying an additional 226,306 shares during the period. Geode Capital Management LLC boosted its stake in CME Group by 1.8% during the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock worth $1,823,964,000 after buying an additional 142,692 shares during the period. Bank of Montreal Can boosted its stake in CME Group by 41.8% during the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock worth $224,432,000 after buying an additional 303,169 shares during the period. Finally, Massachusetts Financial Services Co. MA boosted its stake in CME Group by 18.3% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,826,501 shares of the financial services provider’s stock worth $403,017,000 after buying an additional 283,171 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Insiders Place Their Bets
In other news, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the transaction, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 14.26 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,274 shares of company stock valued at $1,648,071. 0.30% of the stock is owned by corporate insiders.
CME Group Stock Up 0.1 %
CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the company earned $2.25 earnings per share. The firm’s revenue for the quarter was up 18.4% on a year-over-year basis. Research analysts expect that CME Group Inc. will post 10.18 earnings per share for the current fiscal year.
CME Group declared that its board has authorized a share repurchase plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.
CME Group Increases Dividend
The business also recently disclosed a dividend, which was paid on Thursday, January 16th. Shareholders of record on Friday, December 27th were issued a dividend of $5.80 per share. The ex-dividend date was Friday, December 27th. This is a boost from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio (DPR) is presently 48.37%.
Analyst Ratings Changes
Several brokerages have weighed in on CME. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research note on Tuesday, October 8th. The Goldman Sachs Group raised their price objective on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research note on Thursday, October 3rd. Morgan Stanley raised their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. TD Cowen started coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Finally, Barclays raised their price objective on shares of CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research note on Monday, December 9th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $229.27.
Read Our Latest Research Report on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Oracle Announces Game-Changing News for the AI Industry
- Business Services Stocks Investing
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Short Selling – The Pros and Cons
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.